Rho GTPases activity is central to melanoma cells, and indeed we have previously shown that RhoA inhibition induced the up-regulation of several immune-interacting molecules including MHC Class-I, CD80/CD86 costimulatory molecules and FasL, which like CD70 belongs to the TNF superfamily [16–18]. The gene discussed is RHOA; the disease is melanoma.